Clinical Trial Update: Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q Codeletion [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing radiotherapy alone to concurrent chemoradiotherapy with temozolomide in patients with Grade III gliomas without 1p/19q codeletion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Jong Hoon Kim | Conditions: Anaplastic Glioma of Brain, Loss of Chromosomes 1p/19q | Phase 2 | Status: UNKNOWN